Voor de behandeling wordt u gevraagd u zich met een lege maag te melden. Eten en dranken zijn daarvoor niet toegestaan.

Er moeten enkele voorzorgsmaatregelen worden genomen gedurende de eerste 24 uur na de Selective Internal Radiation Therapy (SIRT) procedure.

Deze voorzorgsmaatregelen omvatten:

  • Het grondig wassen van uw handen nadat u naar het toilet bent geweest;
  • Schoonmaken van gemorste lichaamsvloeistoffen, zoals bloed, urine of ontlasting en deze lozen in het toilet.

U ontvangt meer informatie over deze voorzorgsmaatregelen van uw behandel team.

Na 2 weken zal slechts 3 % van de initiële straling zijn overgebleven en na 1 maand is het geheel verdwenen.

De hier gepresenteerde informatie is onderhevig aan het beleid van de arts of de organisatie.




Now leaving sirtex.com

You are about to leave the Sirtex Web site. This link is provided to you as a service and will take you to a site maintained by a third party who is solely responsible for the content.

Please be aware that Sirtex takes no responsibility for content of these external sites, nor do we endorse, warrant or guarantee the products, services or information described or offered on other internet sites.

Click 'Continue' to proceed to the third-party Web site.

Continue

×

Now leaving sirtex.com

You are about to leave the Sirtex Website. This link is provided to you as a service and will take you to the Sirtex Virtual Booth.

Sirtex is responsible for the content of the Virtual Booth, which is hosted on a website maintained by a third-party. Except for Sirtex’s Virtual Booth experience, please be aware that Sirtex takes no responsibility for the other content of these external sites, nor do we endorse, warrant, or guarantee the products, services or information described or offered on other internet sites.

Continue

×

You are now leaving your current sirtex.com region

The Sirtex site you are linking to is intended only for healthcare practitioners and patients outside your current region. Any products discussed herein may have different approved product labeling; therefore, any information provided may not be appropriate for use in your region.

Click 'Continue' to proceed to the other Sirtex region Web site.

Continue

×

Effective May 7, 2021, SIR-Spheres will have the following indication for use:
SIR-Spheres Y-90 resin microspheres are indicated for the treatment of unresectable hepatocellular carcinoma (HCC) and unresectable metastatic liver tumors from primary colorectal cancer in patients refractory to or intolerant of chemotherapy.

Click here to view our Technical Bulletin.

Ok